How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic review. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-023-07730-1
PubMed Identifier: 37926806
Publication URI: http://europepmc.org/abstract/MED/37926806
Type: Journal Article/Review
Volume: 24
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215